Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-094039
Filing Date
2025-09-29
Accepted
2025-09-29 06:08:05
Documents
5
Period of Report
2025-09-29

Document Format Files

Seq Description Document Type Size
1 6-K tm2526326-11_6k.htm 6-K 676661
2 GRAPHIC lg_astrazeneca-4c.jpg GRAPHIC 15580
3 GRAPHIC lg_computershare-bw.jpg GRAPHIC 8636
4 GRAPHIC sg_matthewbowden-bw.jpg GRAPHIC 6116
5 GRAPHIC sg_micheldemare-bw.jpg GRAPHIC 12507
  Complete submission text file 0001104659-25-094039.txt   737560
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE United Kingdom CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 251351991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)